Transcranial Magnetic Stimulation in Depression

Depression Clinical Trial

Official title:

Efficacy of Threshold vs. Subthreshold TMS in the Treatment of Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00018746
• Other study ID #: MHBS-037-98S
• Status: Completed
• Phase: Phase 1
• First received: July 3, 2001
• Last updated: January 20, 2009
• Start date: July 1999
• Est. completion date: July 2001

Study information

• Verified date: December 2004
• Source: VA Office of Research and Development
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

The study examines efficacy of repetitive transcranial magnetic stimulation in treating severely depressed patients who are medicated.

Description:

Medicated, treatment resistant, depressed patients are randomized to active or sham repetitive transcranial magnetic stimulation (rTMS). Responding patients go into a six months follow-up period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: July 2001
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older
• Eligibility: severe treatment-resistant depression

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Device:
• repetitive transcranial magnetic stimulation

Locations

Country	Name	City	State
United States	VA Connecticut Healthcare System	West Haven	Connecticut

Sponsors (1)

Lead Sponsor	Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States,